Skip to content

Autologous Point-of-Care Adipose Therapy: Delayed Injury/Scar

Autologous Point-of-Care Adipose Therapy for Reconstruction and Regeneration of Traumatized Skin: Delayed Injury/Scar

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06857435
Enrollment
40
Registered
2025-03-04
Start date
2025-11-04
Completion date
2028-10-30
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns, Contracture Scar, Surgical Injury

Keywords

burns, scar contracture

Brief summary

The goal of this study is to explore if an adipose-based therapeutic strategy can treat contracted scars secondary to soft-tissue burn wounds in injured individuals, especially those with severe burns or soft-tissue loss. The main question it aims to answer are: \- Can autologous layered composite grafting demonstrate non-inferiority compared to full-thickness skin grafting for delayed reconstruction of post-burn or trauma scar contracture? Researchers will compare the single-stage autologous layered composite grafting method to traditional methods to see if it improves healing outcomes, minimizes scarring, and reduces infection risk. Participants will: * Receive fat grafting at time of scar revision. * Undergo simultaneous split-thickness skin grafting for full soft-tissue reconstruction.

Detailed description

Soft-tissue injuries from blasts, burns, or multiple traumas can cause severe damage, leading to loss of function, lower quality of life, long recovery times, and inability to work. When these injuries involve deep burns or full-thickness tissue loss in areas that move a lot, they are especially difficult to treat due to the risk of scarring, stiffness, and tissue sticking together. There is a need for a reliable, single-stage treatment that can provide soft, flexible tissue reconstruction with minimal risk, cost, and, complexity. To address this issue, the investigators propose a fat-based approach to reconstruction. Fat tissue is easily available from the patient's own body and carries many benefits in reconstructive surgery. Our team has shown that using a layer of fat immediately in treatment creates a soft, vascular layer that reduces scarring, improves tissue volume, and supports a one-stage, multi-layer reconstruction without the need for complex surgery or causing harm to the donor area. The purpose of this study is to compare this reconstructive approach under the following conditions: • Demonstrate non-inferiority of autologous layered composite grafting to full-thickness skin grafting for delayed reconstruction of post-burn/trauma scar contracture. Evaluators including dedicated observers will be blinded to treatment group/strategy.

Interventions

PROCEDUREFull Thickness Skin Graft (FTSG)

Full thickness skin in FTSGs are harvested by different means by surgeon preference and standard of care. Typically an area of skin with matching color and texture to the site which needs reconstruction is identified from a hidden and/or non-cosmetic area and collected via excision. After excision the donor site is closed and the graft is thinned by using a scalpel or scissors to remove excess fat or other soft tissues from the deep surface before being placed in the donor site.

PROCEDUREBase of wound fat graft with Split Thickness Skin Graft (STSG) Reconstruction (Autologous Layered Composite Grafting).

Autologous Layered Composite Grafting consists of the layered strategy of simultaneous fat and skin grafting. Fat is harvested by minimally invasive liposuction and applied directly to the wound base without any chemical or biologic processing. Skin is harvested as a split thickness skin graft by dermatome and applied over the layer of adipose tissue.

Sponsors

University of Pittsburgh
Lead SponsorOTHER
Armed Forces Institute of Regenerative Medicine
CollaboratorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Autologous Layered Composite Grafting consists of the layered strategy of simultaneous fat and skin grafting. Fat is harvested by minimally invasive liposuction and applied directly to the wound base without any chemical or biologic processing. Skin is harvested as per standard of care and applied either to the wound bed directly as per controls or to the layer of adipose tissue. Investigators will compare delayed reconstruction of scar contracture across two treatment arms (40 subjects). * Group 1: Full thickness skin graft (FTSG) Reconstruction; * Group 2: Base of wound fat graft with STSG Reconstruction (Autologous Layered Composite Grafting).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The proposed study will include adult patients 18 years of age or older, * male or female, * civilian, military, active duty or retired veterans * presenting for scar contracture release and reconstruction at any level. * Additional inclusion criteria includes willingness to be randomized to receive a fat graft.

Exclusion criteria

* Age \< 18 years of age, * active infection, * medical co-morbidities or anatomic configuration deemed by the physician to be a concern for safety, * unwilling or unable to comply with study procedures, * radiation to the site of interest, * prisoners and/or vulnerable populations. * In addition, candidates that are pregnant or plan to become pregnant in the next year, will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Change in scar contracture, as measured by change in scar surface area sizeFrom surgery to 9-month clinical endpoint.Contracture as measured by change in surface area of reconstruction between time of surgery and 9-month clinical endpoint/maturation of reconstruction. These data will be derived by serial photography.

Secondary

MeasureTime frameDescription
Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability).From surgery to 9-month clinical endpoint.Incidence of adverse events will be reported for all study participants.
Total score on the Patient and Observer Scar Assessment Scale (POSAS): Pigmentation, Pliability, Vascularity, Thickness, Relief, and Surface Area, collected at the 9 month follow up visit. RemoveFrom surgery to 9-month clinical endpoint.POSAS measures subjective assessment on a 1-10 scale from normal skin to worst scar imaginable across 6 metrics (surface area, vascularity, pigmentation, thickness, pliability and relief). The lowest sum score, reflecting normal skin, is 6 and the highest score, reflecting the worst imaginable scar, is 60.
Number of Operative EncountersFrom surgery to 9-month clinical endpoint.The investigators will additionally assess early outcome metrics including number of operative encounters.
Percent Graft TakeFrom surgery to 9-month clinical endpoint.The investigators will additionally assess early outcome metrics including percent graft take (% of surface area).
Time to Final Healing/Graft TakeFrom surgery to 9-month clinical endpoint.The investigators will additionally assess early outcome metrics including, time to final healing/graft take in days.
Tissue ThicknessFrom surgery to 9-month clinical endpoint.The investigators will measure tissue thickness as determined by ultrasound.
Pliability (Tensiometry/Cutometry)From surgery to 9-month clinical endpoint.The investigators will utilize a noninvasive cutometer/tensiometer to determine tissue pliability.
Tissue Adhesion/MobilityFrom surgery to 9-month clinical endpoint.The investigators will measure tissue mobility/resistance to adhesion under non-invasive tissue stretch.

Countries

United States

Contacts

CONTACTEleanor Shirley
shirleye@upmc.edu412-641-8676
CONTACTPatsy Simon
simopa@UPMC.EDU412-641-8676
PRINCIPAL_INVESTIGATORFrancesco Egro

University of Pittsburgh

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026